Medicinova (MNOV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.42, -2.07% vs the prior close of $1.45.
- Volume 79.18K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MNOV dips 2.1% to $1.42, a 1-month low, 4 down days in a row. Closed at $1.42, -2.07% vs the prior close of $1.45. Day range $1.42–$1.50, opened at $1.47.
MNOV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MNOV dips 2.1% to $1.42, a 1-month low, 4 down days in a row
- Closed at $1.42, -2.07% vs the prior close of $1.45. Day range $1.42–$1.50, opened at $1.47.
- Volume was 79.18K shares, 0.2x its 50-day average of 405.79K — lighter than usual.
- Price is -20.0% vs its 50-day average ($1.78) and -6.2% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 9% of that range, 63.6% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — MNOV dips 1.4% to $1.45, a 1-month low, 3 down days in a row
- Closed at $1.45, -1.36% vs the prior close of $1.47. Day range $1.45–$1.53, opened at $1.47.
- Volume was 58.80K shares, 0.1x its 50-day average of 404.89K — lighter than usual.
- Price is -18.3% vs its 50-day average ($1.77) and -4.2% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 10% of that range, 62.8% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — MNOV dips 2.0% to $1.47, a 1-month low
- Closed at $1.47, -2.00% vs the prior close of $1.50. Day range $1.46–$1.55, opened at $1.51.
- Volume was 96.20K shares, 0.2x its 50-day average of 404.62K — lighter than usual.
- Price is -17.1% vs its 50-day average ($1.77) and -2.8% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 11% of that range, 62.3% below the 52-week high.
Oct 13, 2026 — MNOV dips 2.6% to $1.50, a 1-month low
- Closed at $1.50, -2.60% vs the prior close of $1.54. Day range $1.50–$1.56, opened at $1.56.
- Volume was 34.80K shares, 0.1x its 50-day average of 404.71K — lighter than usual.
- Price is -15.2% vs its 50-day average ($1.77) and -0.8% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 12% of that range, 61.5% below the 52-week high.
Oct 12, 2026 — MNOV rises 1.3% to $1.54
- Closed at $1.54, +1.32% vs the prior close of $1.52. Day range $1.48–$1.58, opened at $1.49.
- Volume was 127.80K shares, 0.3x its 50-day average of 402.32K — lighter than usual.
- Price is -12.8% vs its 50-day average ($1.77) and +1.9% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 14% of that range, 60.5% below the 52-week high.
Oct 9, 2026 — MNOV dips 1.3% to $1.52, a 1-month low, 5 down days in a row
- Closed at $1.52, -1.30% vs the prior close of $1.54. Day range $1.52–$1.57, opened at $1.54.
- Volume was 69.90K shares, 0.2x its 50-day average of 402.20K — lighter than usual.
- Price is -13.7% vs its 50-day average ($1.76) and +0.7% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 13% of that range, 61.0% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — MNOV slides 4.3% to $1.54, a 1-month low, 4 down days in a row
- Closed at $1.54, -4.35% vs the prior close of $1.61. Day range $1.53–$1.61, opened at $1.60.
- Volume was 109.40K shares, 0.3x its 50-day average of 400.36K — lighter than usual.
- Price is -12.4% vs its 50-day average ($1.76) and +2.1% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 14% of that range, 60.5% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — MNOV dips 2.4% to $1.61, a 1-month low, 3 down days in a row
- Closed at $1.61, -2.42% vs the prior close of $1.65. Day range $1.60–$1.68, opened at $1.65.
- Volume was 78.00K shares, 0.2x its 50-day average of 399.96K — lighter than usual.
- Price is -8.1% vs its 50-day average ($1.75) and +6.7% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 16% of that range, 58.7% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — MNOV slides 6.3% to $1.65
- Closed at $1.65, -6.25% vs the prior close of $1.76. Day range $1.65–$1.72, opened at $1.72.
- Volume was 120.00K shares, 0.3x its 50-day average of 397.92K — lighter than usual.
- Price is -5.6% vs its 50-day average ($1.75) and +9.4% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 18% of that range, 57.7% below the 52-week high.
Oct 5, 2026 — MNOV dips 1.1% to $1.76
- Closed at $1.76, -1.12% vs the prior close of $1.78. Day range $1.74–$1.89, opened at $1.87.
- Volume was 212.90K shares, 0.5x its 50-day average of 394.19K — lighter than usual.
- Price is +1.1% vs its 50-day average ($1.74) and +16.8% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 22% of that range, 54.9% below the 52-week high.
Oct 2, 2026 — MNOV jumps 9.2% to $1.78
- Closed at $1.78, +9.20% vs the prior close of $1.63. Day range $1.67–$1.84, opened at $1.67.
- Volume was 274.50K shares, 0.7x its 50-day average of 389.38K.
- Price is +2.8% vs its 50-day average ($1.73) and +18.2% vs its 200-day average ($1.51).
- 52-week range $1.17–$3.90; today's close sits at 22% of that range, 54.4% below the 52-week high.
MNOV latest news & SEC filings
Every SEC filing by or about MNOV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- 3D Investment Partners Pte. Ltd. & 3D Opportunity Master Fund sold 640,000 shares at $2.70 (≈$1.73M) on Sep 25, 2026; now holds 4,862,047
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 28, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Sep 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
Aug 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $458.44K (prior year $134.60K) (+240.6% vs Jun 30, 2025)
- Net income: -$2.31M (prior year -$3.28M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.05 (prior year -$0.07) (loss narrowed vs Jun 30, 2025)
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade MNOV
- Last results release: Feb 20, 2026 (8-K Item 2.02). Previous ones: Mar 28, 2013, Mar 29, 2012, Nov 15, 2011. Based on that rhythm, the next report is likely around May 22, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.04% (largest 18.6%). That is a volatile stock.
- Liquidity: about 417.43K shares (≈$592.76K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.42 vs a range of $1.17–$3.90 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 8 sales; latest: Opportunity Master Fund 3D sold 640,000 shares on Sep 25, 2026.
- Latest filings: 8-K Sep 28, 2026; 8-K Sep 2, 2026; 8-K Aug 19, 2026.
- Share count: 49.22M shares outstanding (Aug 11, 2026), +0.4% vs a year earlier.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MNOV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.47 | 1.50 | 1.42 | 1.42 | 79.18K |
| Oct 15, 2026 | 1.47 | 1.53 | 1.45 | 1.45 | 58.80K |
| Oct 14, 2026 | 1.51 | 1.55 | 1.46 | 1.47 | 96.20K |
| Oct 13, 2026 | 1.56 | 1.56 | 1.50 | 1.50 | 34.80K |
| Oct 12, 2026 | 1.49 | 1.58 | 1.48 | 1.54 | 127.80K |
| Oct 9, 2026 | 1.54 | 1.57 | 1.52 | 1.52 | 69.90K |
| Oct 8, 2026 | 1.60 | 1.61 | 1.53 | 1.54 | 109.40K |
| Oct 7, 2026 | 1.65 | 1.68 | 1.60 | 1.61 | 78.00K |
| Oct 6, 2026 | 1.72 | 1.72 | 1.65 | 1.65 | 120.00K |
| Oct 5, 2026 | 1.87 | 1.89 | 1.74 | 1.76 | 212.90K |
| Oct 2, 2026 | 1.67 | 1.84 | 1.67 | 1.78 | 274.50K |
| Oct 1, 2026 | 1.69 | 1.72 | 1.63 | 1.63 | 263.20K |
| Sep 30, 2026 | 1.86 | 1.86 | 1.66 | 1.68 | 369.80K |
| Sep 29, 2026 | 2.05 | 2.07 | 1.77 | 1.92 | 595.10K |
| Sep 28, 2026 | 2.40 | 2.45 | 1.69 | 2.10 | 1.62M |
| Sep 25, 2026 | 2.68 | 2.69 | 2.53 | 2.58 | 251.90K |
| Sep 24, 2026 | 2.67 | 2.67 | 2.48 | 2.65 | 452.80K |
| Sep 23, 2026 | 2.90 | 3.02 | 2.75 | 2.80 | 395.80K |
| Sep 22, 2026 | 3.16 | 3.30 | 2.90 | 2.90 | 2.47M |
| Sep 21, 2026 | 3.28 | 3.40 | 3.03 | 3.30 | 666.90K |
About Medicinova
Medicinova (MNOV) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LA JOLLA, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1226616.
MNOV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Carolyn Beaver | Director | Jun 25, 2026 |
| Nicole Lemerond | Director | Jun 25, 2026 |
| Hideki Nagao | Director | Jun 25, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Yuichi Iwaki | President and CEO | Jan 20, 2026 |
| Kazuko Matsuda | Chief Medical Officer | Jan 20, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Opportunity Master Fund 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Opportunity Master Fund 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Investment Partners Pte. Ltd. 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Investment Partners Pte. Ltd. 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Opportunity Master Fund 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Opportunity Master Fund 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Investment Partners Pte. Ltd. 3D | Sale | 640,000 | $2.70 |
| Sep 25, 2026 | Investment Partners Pte. Ltd. 3D | Sale | 640,000 | $2.70 |
MNOV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $409.66K | $-12.00M | -0.24 | $-9.81M |
| Dec 31, 2024 | — | $-11.05M | -0.23 | $-10.64M |
| Dec 31, 2023 | $1.00M | $-8.57M | -0.17 | $-7.43M |
| Dec 31, 2022 | — | $-14.07M | -0.29 | $-12.91M |
| Dec 31, 2021 | $4.04M | $-10.13M | -0.21 | $-9.38M |
Latest balance sheet: total assets $40.43M, total liabilities $3.16M, cash $25.42M (as of Jun 30, 2026).
MNOV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Feb 20, 2026 | 8-K Item 2.02 (results) | $1.50 |
| Mar 28, 2013 | 8-K Item 2.02 (results) | — |
| Mar 29, 2012 | 8-K Item 2.02 (results) | — |
| Nov 15, 2011 | 8-K Item 2.02 (results) | — |
| Aug 16, 2011 | 8-K Item 2.02 (results) | — |
| May 17, 2011 | 8-K Item 2.02 (results) | — |
| Mar 31, 2011 | 8-K Item 2.02 (results) | — |
| Mar 24, 2011 | 8-K Item 2.02 (results) | — |
| Nov 16, 2010 | 8-K Item 2.02 (results) | — |
| Aug 16, 2010 | 8-K Item 2.02 (results) | — |
| May 17, 2010 | 8-K Item 2.02 (results) | — |
| Mar 24, 2010 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MNOV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.